SR One Capital Management, LP
Redwood City, CA · CIK 1910264 · 13F filing filed 2024-08-13
SEC-registered investment adviser since 2020 · limited partnership
- Assets managed$2.4bn
- Staff28 · 15 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds19 · $2.4bn gross assets
- Websitesrone.com
- Form ADV · 2026-03-31SEC adviser record
$319.4m
reported value
-12.3% vs Q1 2024
9positions
100.0%in top 10
3 new
0 added
0 reduced
0 sold out
vs Q1 2024
Holdings, Q2 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ARCELLX INC ACLX | $129.5m40.55% | Unchanged |
| CRISPR THERAPEUTICS AG CRSP | $56.7m17.74% | Unchanged |
| ARS PHARMACEUTICALS INC SPRY | $34.1m10.69% | Unchanged |
| ALUMIS INC ALMS | $26.1m8.16% | New |
| MINERALYS THERAPEUTICS INC MLYS | $23.6m7.39% | Unchanged |
| DESIGN THERAPEUTICS INC DSGN | $21.9m6.85% | Unchanged |
| NKARTA INC NKTX | $19.7m6.17% | Unchanged |
| ENGENE HOLDINGS INC COM | $4.7m1.48% | New |
| KALA BIO INC COM NEW | $3.1m0.98% | New |